img

Global Brigatinib Tablet Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Brigatinib Tablet Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Brigatinib Tablet is a cancer medicine that is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) who have been treated before with a cancer medicine called crizotinib.
The global Brigatinib Tablet market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Brigatinib Tablet is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Brigatinib Tablet is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Brigatinib Tablet is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Brigatinib Tablet include ARIAD Pharmaceuticals. etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Brigatinib Tablet, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Brigatinib Tablet by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Brigatinib Tablet market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Brigatinib Tablet market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


ARIAD Pharmaceuticals
By Type
30mg
50mg
180mg
By Application
Hospital
Pharmacy
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Brigatinib Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Brigatinib Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brigatinib Tablet sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Brigatinib Tablet Definition
1.2 Market by Type
1.2.1 Global Brigatinib Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 30mg
1.2.3 50mg
1.2.4 180mg
1.3 Market Segment by Application
1.3.1 Global Brigatinib Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Brigatinib Tablet Sales
2.1 Global Brigatinib Tablet Revenue Estimates and Forecasts 2018-2034
2.2 Global Brigatinib Tablet Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Brigatinib Tablet Revenue by Region
2.3.1 Global Brigatinib Tablet Revenue by Region (2018-2024)
2.3.2 Global Brigatinib Tablet Revenue by Region (2024-2034)
2.4 Global Brigatinib Tablet Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Brigatinib Tablet Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Brigatinib Tablet Sales Quantity by Region
2.6.1 Global Brigatinib Tablet Sales Quantity by Region (2018-2024)
2.6.2 Global Brigatinib Tablet Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Brigatinib Tablet Sales Quantity by Manufacturers
3.1.1 Global Brigatinib Tablet Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Brigatinib Tablet Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Brigatinib Tablet Sales in 2022
3.2 Global Brigatinib Tablet Revenue by Manufacturers
3.2.1 Global Brigatinib Tablet Revenue by Manufacturers (2018-2024)
3.2.2 Global Brigatinib Tablet Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Brigatinib Tablet Revenue in 2022
3.3 Global Brigatinib Tablet Sales Price by Manufacturers
3.4 Global Key Players of Brigatinib Tablet, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Brigatinib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Brigatinib Tablet, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Brigatinib Tablet, Product Offered and Application
3.8 Global Key Manufacturers of Brigatinib Tablet, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Brigatinib Tablet Sales Quantity by Type
4.1.1 Global Brigatinib Tablet Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Brigatinib Tablet Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Brigatinib Tablet Sales Quantity Market Share by Type (2018-2034)
4.2 Global Brigatinib Tablet Revenue by Type
4.2.1 Global Brigatinib Tablet Historical Revenue by Type (2018-2024)
4.2.2 Global Brigatinib Tablet Forecasted Revenue by Type (2024-2034)
4.2.3 Global Brigatinib Tablet Revenue Market Share by Type (2018-2034)
4.3 Global Brigatinib Tablet Price by Type
4.3.1 Global Brigatinib Tablet Price by Type (2018-2024)
4.3.2 Global Brigatinib Tablet Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Brigatinib Tablet Sales Quantity by Application
5.1.1 Global Brigatinib Tablet Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Brigatinib Tablet Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Brigatinib Tablet Sales Quantity Market Share by Application (2018-2034)
5.2 Global Brigatinib Tablet Revenue by Application
5.2.1 Global Brigatinib Tablet Historical Revenue by Application (2018-2024)
5.2.2 Global Brigatinib Tablet Forecasted Revenue by Application (2024-2034)
5.2.3 Global Brigatinib Tablet Revenue Market Share by Application (2018-2034)
5.3 Global Brigatinib Tablet Price by Application
5.3.1 Global Brigatinib Tablet Price by Application (2018-2024)
5.3.2 Global Brigatinib Tablet Price Forecast by Application (2024-2034)
6 North America
6.1 North America Brigatinib Tablet Sales by Company
6.1.1 North America Brigatinib Tablet Revenue by Company (2018-2024)
6.1.2 North America Brigatinib Tablet Sales Quantity by Company (2018-2024)
6.2 North America Brigatinib Tablet Market Size by Type
6.2.1 North America Brigatinib Tablet Sales Quantity by Type (2018-2034)
6.2.2 North America Brigatinib Tablet Revenue by Type (2018-2034)
6.3 North America Brigatinib Tablet Market Size by Application
6.3.1 North America Brigatinib Tablet Sales Quantity by Application (2018-2034)
6.3.2 North America Brigatinib Tablet Revenue by Application (2018-2034)
6.4 North America Brigatinib Tablet Market Size by Country
6.4.1 North America Brigatinib Tablet Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Brigatinib Tablet Revenue by Country (2018-2034)
6.4.3 North America Brigatinib Tablet Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Brigatinib Tablet Sales by Company
7.1.1 Europe Brigatinib Tablet Sales Quantity by Company (2018-2024)
7.1.2 Europe Brigatinib Tablet Revenue by Company (2018-2024)
7.2 Europe Brigatinib Tablet Market Size by Type
7.2.1 Europe Brigatinib Tablet Sales Quantity by Type (2018-2034)
7.2.2 Europe Brigatinib Tablet Revenue by Type (2018-2034)
7.3 Europe Brigatinib Tablet Market Size by Application
7.3.1 Europe Brigatinib Tablet Sales Quantity by Application (2018-2034)
7.3.2 Europe Brigatinib Tablet Revenue by Application (2018-2034)
7.4 Europe Brigatinib Tablet Market Size by Country
7.4.1 Europe Brigatinib Tablet Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Brigatinib Tablet Revenue by Country (2018-2034)
7.4.3 Europe Brigatinib Tablet Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Brigatinib Tablet Sales by Company
8.1.1 China Brigatinib Tablet Sales Quantity by Company (2018-2024)
8.1.2 China Brigatinib Tablet Revenue by Company (2018-2024)
8.2 China Brigatinib Tablet Market Size by Type
8.2.1 China Brigatinib Tablet Sales Quantity by Type (2018-2034)
8.2.2 China Brigatinib Tablet Revenue by Type (2018-2034)
8.3 China Brigatinib Tablet Market Size by Application
8.3.1 China Brigatinib Tablet Sales Quantity by Application (2018-2034)
8.3.2 China Brigatinib Tablet Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Brigatinib Tablet Sales by Company
9.1.1 APAC Brigatinib Tablet Sales Quantity by Company (2018-2024)
9.1.2 APAC Brigatinib Tablet Revenue by Company (2018-2024)
9.2 APAC Brigatinib Tablet Market Size by Type
9.2.1 APAC Brigatinib Tablet Sales Quantity by Type (2018-2034)
9.2.2 APAC Brigatinib Tablet Revenue by Type (2018-2034)
9.3 APAC Brigatinib Tablet Market Size by Application
9.3.1 APAC Brigatinib Tablet Sales Quantity by Application (2018-2034)
9.3.2 APAC Brigatinib Tablet Revenue by Application (2018-2034)
9.4 APAC Brigatinib Tablet Market Size by Region
9.4.1 APAC Brigatinib Tablet Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Brigatinib Tablet Revenue by Region (2018-2034)
9.4.3 APAC Brigatinib Tablet Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Brigatinib Tablet Sales by Company
10.1.1 Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Brigatinib Tablet Market Size by Type
10.2.1 Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Brigatinib Tablet Market Size by Application
10.3.1 Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Brigatinib Tablet Market Size by Country
10.4.1 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 ARIAD Pharmaceuticals
11.1.1 ARIAD Pharmaceuticals Company Information
11.1.2 ARIAD Pharmaceuticals Overview
11.1.3 ARIAD Pharmaceuticals Brigatinib Tablet Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 ARIAD Pharmaceuticals Brigatinib Tablet Products and Services
11.1.5 ARIAD Pharmaceuticals Brigatinib Tablet SWOT Analysis
11.1.6 ARIAD Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Brigatinib Tablet Value Chain Analysis
12.2 Brigatinib Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brigatinib Tablet Production Mode & Process
12.4 Brigatinib Tablet Sales and Marketing
12.4.1 Brigatinib Tablet Sales Channels
12.4.2 Brigatinib Tablet Distributors
12.5 Brigatinib Tablet Customers
13 Market Dynamics
13.1 Brigatinib Tablet Industry Trends
13.2 Brigatinib Tablet Market Drivers
13.3 Brigatinib Tablet Market Challenges
13.4 Brigatinib Tablet Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Brigatinib Tablet Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 30mg
Table 3. Major Manufacturers of 50mg
Table 4. Major Manufacturers of 180mg
Table 5. Global Brigatinib Tablet Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Brigatinib Tablet Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Brigatinib Tablet Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Brigatinib Tablet Revenue Market Share by Region (2018-2024)
Table 9. Global Brigatinib Tablet Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Brigatinib Tablet Revenue Market Share by Region (2024-2034)
Table 11. Global Brigatinib Tablet Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 12. Global Brigatinib Tablet Sales by Region (2018-2024) & (K MT)
Table 13. Global Brigatinib Tablet Sales Market Share by Region (2018-2024)
Table 14. Global Brigatinib Tablet Sales by Region (2024-2034) & (K MT)
Table 15. Global Brigatinib Tablet Sales Market Share by Region (2024-2034)
Table 16. Global Brigatinib Tablet Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 17. Global Brigatinib Tablet Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Brigatinib Tablet Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Brigatinib Tablet Revenue Share by Manufacturers (2018-2024)
Table 20. Global Brigatinib Tablet Price by Manufacturers 2018-2024 (USD/MT)
Table 21. Global Key Players of Brigatinib Tablet, Industry Ranking, 2021 VS 2022
Table 22. Global Brigatinib Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Brigatinib Tablet by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brigatinib Tablet as of 2022)
Table 24. Global Key Manufacturers of Brigatinib Tablet, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Brigatinib Tablet, Product Offered and Application
Table 26. Global Key Manufacturers of Brigatinib Tablet, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Brigatinib Tablet Sales Quantity by Type (2018-2024) & (K MT)
Table 29. Global Brigatinib Tablet Sales Quantity by Type (2024-2034) & (K MT)
Table 30. Global Brigatinib Tablet Sales Quantity Share by Type (2018-2024)
Table 31. Global Brigatinib Tablet Sales Quantity Share by Type (2024-2034)
Table 32. Global Brigatinib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Brigatinib Tablet Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Brigatinib Tablet Revenue Share by Type (2018-2024)
Table 35. Global Brigatinib Tablet Revenue Share by Type (2024-2034)
Table 36. Brigatinib Tablet Price by Type (2018-2024) & (USD/MT)
Table 37. Global Brigatinib Tablet Price Forecast by Type (2024-2034) & (USD/MT)
Table 38. Global Brigatinib Tablet Sales Quantity by Application (2018-2024) & (K MT)
Table 39. Global Brigatinib Tablet Sales Quantity by Application (2024-2034) & (K MT)
Table 40. Global Brigatinib Tablet Sales Quantity Share by Application (2018-2024)
Table 41. Global Brigatinib Tablet Sales Quantity Share by Application (2024-2034)
Table 42. Global Brigatinib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Brigatinib Tablet Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Brigatinib Tablet Revenue Share by Application (2018-2024)
Table 45. Global Brigatinib Tablet Revenue Share by Application (2024-2034)
Table 46. Brigatinib Tablet Price by Application (2018-2024) & (USD/MT)
Table 47. Global Brigatinib Tablet Price Forecast by Application (2024-2034) & (USD/MT)
Table 48. North America Brigatinib Tablet Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Brigatinib Tablet Sales Quantity by Company (2018-2024) & (K MT)
Table 50. North America Brigatinib Tablet Sales Quantity by Type (2018-2024) & (K MT)
Table 51. North America Brigatinib Tablet Sales Quantity by Type (2024-2034) & (K MT)
Table 52. North America Brigatinib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Brigatinib Tablet Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Brigatinib Tablet Sales Quantity by Application (2018-2024) & (K MT)
Table 55. North America Brigatinib Tablet Sales Quantity by Application (2024-2034) & (K MT)
Table 56. North America Brigatinib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Brigatinib Tablet Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Brigatinib Tablet Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Brigatinib Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Brigatinib Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Brigatinib Tablet Sales Quantity by Country (2018-2024) & (K MT)
Table 62. North America Brigatinib Tablet Sales Quantity by Country (2024-2034) & (K MT)
Table 63. Europe Brigatinib Tablet Sales Quantity by Company (2018-2024) & (K MT)
Table 64. Europe Brigatinib Tablet Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Brigatinib Tablet Sales Quantity by Type (2018-2024) & (K MT)
Table 66. Europe Brigatinib Tablet Sales Quantity by Type (2024-2034) & (K MT)
Table 67. Europe Brigatinib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Brigatinib Tablet Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Brigatinib Tablet Sales Quantity by Application (2018-2024) & (K MT)
Table 70. Europe Brigatinib Tablet Sales Quantity by Application (2024-2034) & (K MT)
Table 71. Europe Brigatinib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Brigatinib Tablet Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Brigatinib Tablet Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Brigatinib Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Brigatinib Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Brigatinib Tablet Sales Quantity by Country (2018-2024) & (K MT)
Table 77. Europe Brigatinib Tablet Sales Quantity by Country (2024-2034) & (K MT)
Table 78. China Brigatinib Tablet Sales Quantity by Company (2018-2024) & (K MT)
Table 79. China Brigatinib Tablet Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Brigatinib Tablet Sales Quantity by Type (2018-2024) & (K MT)
Table 81. China Brigatinib Tablet Sales Quantity by Type (2024-2034) & (K MT)
Table 82. China Brigatinib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Brigatinib Tablet Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Brigatinib Tablet Sales Quantity by Application (2018-2024) & (K MT)
Table 85. China Brigatinib Tablet Sales Quantity by Application (2024-2034) & (K MT)
Table 86. China Brigatinib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Brigatinib Tablet Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Brigatinib Tablet Sales Quantity by Company (2018-2024) & (K MT)
Table 89. APAC Brigatinib Tablet Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Brigatinib Tablet Sales Quantity by Type (2018-2024) & (K MT)
Table 91. APAC Brigatinib Tablet Sales Quantity by Type (2024-2034) & (K MT)
Table 92. APAC Brigatinib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Brigatinib Tablet Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Brigatinib Tablet Sales Quantity by Application (2018-2024) & (K MT)
Table 95. APAC Brigatinib Tablet Sales Quantity by Application (2024-2034) & (K MT)
Table 96. APAC Brigatinib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Brigatinib Tablet Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Brigatinib Tablet Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Brigatinib Tablet Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Brigatinib Tablet Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Brigatinib Tablet Sales Quantity by Region (2018-2024) & (K MT)
Table 102. APAC Brigatinib Tablet Sales Quantity by Region (2024-2034) & (K MT)
Table 103. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Company (2018-2024) & (K MT)
Table 104. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Type (2018-2024) & (K MT)
Table 106. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Type (2024-2034) & (K MT)
Table 107. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Application (2018-2024) & (K MT)
Table 110. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Application (2024-2034) & (K MT)
Table 111. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Brigatinib Tablet Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Country (2018-2024) & (K MT)
Table 117. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity by Country (2024-2034) & (K MT)
Table 118. ARIAD Pharmaceuticals Company Information
Table 119. ARIAD Pharmaceuticals Description and Overview
Table 120. ARIAD Pharmaceuticals Brigatinib Tablet Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 121. ARIAD Pharmaceuticals Brigatinib Tablet Product and Services
Table 122. ARIAD Pharmaceuticals Brigatinib Tablet SWOT Analysis
Table 123. ARIAD Pharmaceuticals Recent Developments
Table 124. Key Raw Materials Lists
Table 125. Raw Materials Key Suppliers Lists
Table 126. Brigatinib Tablet Distributors List
Table 127. Brigatinib Tablet Customers List
Table 128. Brigatinib Tablet Market Trends
Table 129. Brigatinib Tablet Market Drivers
Table 130. Brigatinib Tablet Market Challenges
Table 131. Brigatinib Tablet Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Brigatinib Tablet Product Picture
Figure 2. Global Brigatinib Tablet Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Brigatinib Tablet Market Share by Type in 2022 & 2034
Figure 4. 30mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. 180mg Product Picture
Figure 7. Global Brigatinib Tablet Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Brigatinib Tablet Market Share by Application in 2022 & 2034
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Brigatinib Tablet Report Years Considered
Figure 12. Global Brigatinib Tablet Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Brigatinib Tablet Revenue 2018-2034 (US$ Million)
Figure 14. Global Brigatinib Tablet Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Brigatinib Tablet Sales Quantity 2018-2034 (K MT)
Figure 16. Global Brigatinib Tablet Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Brigatinib Tablet Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Brigatinib Tablet Sales Quantity YoY (2018-2034) & (K MT)
Figure 19. North America Brigatinib Tablet Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Brigatinib Tablet Sales Quantity YoY (2018-2034) & (K MT)
Figure 21. Europe Brigatinib Tablet Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Brigatinib Tablet Sales Quantity YoY (2018-2034) & (K MT)
Figure 23. China Brigatinib Tablet Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Brigatinib Tablet Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. APAC Brigatinib Tablet Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. Middle East, Africa and Latin America Brigatinib Tablet Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Brigatinib Tablet Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Brigatinib Tablet Revenue in 2022
Figure 30. Brigatinib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Brigatinib Tablet Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Brigatinib Tablet Revenue Market Share by Type (2018-2034)
Figure 33. Global Brigatinib Tablet Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Brigatinib Tablet Revenue Market Share by Application (2018-2034)
Figure 35. North America Brigatinib Tablet Revenue Market Share by Company in 2022
Figure 36. North America Brigatinib Tablet Sales Quantity Market Share by Company in 2022
Figure 37. North America Brigatinib Tablet Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Brigatinib Tablet Revenue Market Share by Type (2018-2034)
Figure 39. North America Brigatinib Tablet Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Brigatinib Tablet Revenue Market Share by Application (2018-2034)
Figure 41. North America Brigatinib Tablet Revenue Share by Country (2018-2034)
Figure 42. North America Brigatinib Tablet Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Brigatinib Tablet Sales Quantity Market Share by Company in 2022
Figure 46. Europe Brigatinib Tablet Revenue Market Share by Company in 2022
Figure 47. Europe Brigatinib Tablet Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Brigatinib Tablet Revenue Market Share by Type (2018-2034)
Figure 49. Europe Brigatinib Tablet Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Brigatinib Tablet Revenue Market Share by Application (2018-2034)
Figure 51. Europe Brigatinib Tablet Revenue Share by Country (2018-2034)
Figure 52. Europe Brigatinib Tablet Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 54. France Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 58. China Brigatinib Tablet Sales Quantity Market Share by Company in 2022
Figure 59. China Brigatinib Tablet Revenue Market Share by Company in 2022
Figure 60. China Brigatinib Tablet Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Brigatinib Tablet Revenue Market Share by Type (2018-2034)
Figure 62. China Brigatinib Tablet Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Brigatinib Tablet Revenue Market Share by Application (2018-2034)
Figure 64. APAC Brigatinib Tablet Sales Quantity Market Share by Company in 2022
Figure 65. APAC Brigatinib Tablet Revenue Market Share by Company in 2022
Figure 66. APAC Brigatinib Tablet Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Brigatinib Tablet Revenue Market Share by Type (2018-2034)
Figure 68. APAC Brigatinib Tablet Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Brigatinib Tablet Revenue Market Share by Application (2018-2034)
Figure 70. APAC Brigatinib Tablet Revenue Share by Region (2018-2034)
Figure 71. APAC Brigatinib Tablet Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 76. India Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Brigatinib Tablet Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Brigatinib Tablet Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Brigatinib Tablet Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Brigatinib Tablet Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Brigatinib Tablet Revenue Share by Country (2018-2034)
Figure 85. Brazil Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Brigatinib Tablet Revenue (2018-2034) & (US$ Million)
Figure 90. Brigatinib Tablet Value Chain
Figure 91. Brigatinib Tablet Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed